Artículos por temáticas

Intracellular crowding by age-dependent neuromelanin accumulation disrupts neuronal proteostasis and triggers Parkinson disease pathology.

Vila M, Laguna A, Carballo-Carbajal I.

Autophagy. 2019 Nov;15(11):2028-2030. doi: 10.1080/15548627.2019.1659621. Epub 2019 Sep 3.

CHARACTERIZATION BY FRACTAL DIMENSION ANALYSIS OF THE RETINAL CAPILLARY NETWORK IN PARKINSON DISEASE

Shi C, Chen Y, Kwapong WR, Tong Q, Wu S, Zhou Y, Miao H, Shen M, Ye H.

Retina. 2020 Aug;40(8):1483-1491. doi: 10.1097/IAE.0000000000002641.

[A Case of Cerebral Amyloid Angiopathy-related Subarachnoid Hemorrhage with Parkinson Disease Dementia].

Morinaga Y, Nii K, Sakamoto K, Inoue R, Mitsutake T, Hanada H.

No Shinkei Geka. 2019 Aug;47(8):883-892. doi: 10.11477/mf.1436204040. Japanese.

Dexmedetomidine attenuates the induction and reverses the progress of 6-hydroxydopamine- induced parkinsonism; involvement of K(ATP) channels, alpha 2 adrenoceptors and anti-inflammatory mechanisms.

Minaei A, Haghdoost-Yazdi H.

Toxicol Appl Pharmacol. 2019 Aug 30;382:114743. doi: 10.1016/j.taap.2019.114743. [Epub ahead of print]

Cognitive and motor effects of Kinect-based games training in people with and without Parkinson disease: A preliminary study

de Melo Cerqueira TM, de Moura JA, de Lira JO, Leal JC, D'Amelio M, do Santos Mendes FA.

Physiother Res Int. 2020 Jan;25(1):e1807. doi: 10.1002/pri.1807. Epub 2019 Aug 29.

Functional Motor Symptoms in Parkinson's Disease and Functional Parkinsonism: A Systematic Review

Ambar Akkaoui M, Geoffroy PA, Roze E, Degos B, Garcin B.

J Neuropsychiatry Clin Neurosci. 2020 Winter;32(1):4-13. doi: 10.1176/appi.neuropsych.19030058. Epub 2019 Aug 30.

Cytosolic non-vesicular dopamine accumulation as the predominant mechanism for developing non-DOPA responsive parkinsonism in late-stage Huntington disease.

Manalo RVM.

Med Hypotheses. 2019 Aug 21;132:109377. doi: 10.1016/j.mehy.2019.109377. [Epub ahead of print]

Glucocerebrosidase and its relevance to Parkinson disease.

Do J, McKinney C, Sharma P, Sidransky E.

Mol Neurodegener. 2019 Aug 29;14(1):36. doi: 10.1186/s13024-019-0336-2. Review.

Associations between cerebrovascular risk factors and parkinson disease.

Kummer BR, Diaz I, Wu X, Aaroe AE, Chen ML, Iadecola C, Kamel H, Navi BB.

Ann Neurol. 2019 Oct;86(4):572-581. doi: 10.1002/ana.25564. Epub 2019 Aug 29.

Neurogenic Orthostatic Hypotension in Parkinson Disease: A Primer.

Cutsforth-Gregory JK, Low PA.

Neurol Ther. 2019 Aug 27. doi: 10.1007/s40120-019-00152-9. [Epub ahead of print] Review.

Parkinsonism and dysautonomia: Multiple system atrophy?

Wenning GK.

Parkinsonism Relat Disord. 2019 Aug 19. pii: S1353-8020(19)30362-1. doi: 10.1016/j.parkreldis.2019.08.006. [Epub ahead of print] No abstract available.

Using gait analysis' parameters to classify Parkinsonism: A data mining approach.

Ricciardi C, Amboni M, De Santis C, Improta G, Volpe G, Iuppariello L, Ricciardelli G, D'Addio G, Vitale C, Barone P, Cesarelli M; Motion Analysis “Schola Medica Salernitana” Group.; Biomedical Engine

Comput Methods Programs Biomed. 2019 Oct;180:105033. doi: 10.1016/j.cmpb.2019.105033. Epub 2019 Aug 11.

Total glucosides of paeony (TGP) extracted from Radix Paeoniae Alba exerts neuroprotective effects in MPTP-induced experimental parkinsonism by regulating the cAMP/PKA/CREB signaling pathway.

Zheng M, Liu C, Fan Y, Shi D, Jian W.

J Ethnopharmacol. 2019 Dec 5;245:112182. doi: 10.1016/j.jep.2019.112182. Epub 2019 Aug 22.

Severe parkinsonism under treatment with antipsychotic drugs

Druschky K, Bleich S, Grohmann R, Engel RR, Toto S, Neyazi A, Däubl B, Stübner S.

Eur Arch Psychiatry Clin Neurosci. 2020 Feb;270(1):35-47. doi: 10.1007/s00406-019-01060-7. Epub 2019 Aug 23.

Dravet syndrome and parkinsonism: A case report investigating the dopaminergic system.

Deuel L, Collins AE, Maa EH, Barr JP, Kern DS.

Neurology. 2019 Sep 24;93(13):595-596. doi: 10.1212/WNL.0000000000008171. Epub 2019 Aug 23. No abstract available.